BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19602606)

  • 1. Novel approaches to prescribing icodextrin.
    Blake PG
    Perit Dial Int; 2009; 29(4):412-4. PubMed ID: 19602606
    [No Abstract]   [Full Text] [Related]  

  • 2. Icodextrin increases natriuretic peptides in diabetic patients undergoing CAPD.
    Bouchi R; Babazono T; Inoue A; Tanaka M; Tanaka N; Hase M; Ishii A; Iwamoto Y
    Perit Dial Int; 2006; 26(5):604-7. PubMed ID: 16973520
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of exchange-free periods alternating with daily exchanges of icodextrin in the initial treatment of peritoneal dialysis-associated peritonitis: a safety study.
    Yehia M; Muyoma G; Topley N; Collins JF
    Perit Dial Int; 2014; 34(7):810-3. PubMed ID: 25520490
    [No Abstract]   [Full Text] [Related]  

  • 4. Ten years after MIDAS: icodextrin lights and shadows.
    Amici G; Da Rin G; Agostini A; Velo S; Bocci C
    Contrib Nephrol; 2003; (140):76-81. PubMed ID: 12800346
    [No Abstract]   [Full Text] [Related]  

  • 5. Icodextrin reduces insulin resistance in non-diabetic patients undergoing automated peritoneal dialysis: results of a randomized controlled trial (STARCH).
    de Moraes TP; Andreoli MC; Canziani ME; da Silva DR; Caramori JC; Ponce D; Cassi HV; de Andrade Bastos K; Rio DR; Pinto SW; Filho SR; de Campos LG; Olandoski M; Divino-Filho JC; Pecoits-Filho R
    Nephrol Dial Transplant; 2015 Nov; 30(11):1905-11. PubMed ID: 26063787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Icodextrin's effects on peritoneal transport.
    Krediet RT; Ho-dac-Pannekeet MM; Imholz AL; Struijk DG
    Perit Dial Int; 1997; 17(1):35-41. PubMed ID: 9068020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of icodextrin and glucose-containing solutions on insulin resistance in CAPD patients.
    Gürsu EM; Ozdemir A; Yalinbas B; Gürsu RU; Canbakan M; Güven B; Atasoyu EM; Keskin AT; Elçi A; Baru Y
    Clin Nephrol; 2006 Oct; 66(4):263-8. PubMed ID: 17063993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of icodextrin on insulin resistance and adipocytokine profiles in patients on peritoneal dialysis.
    Takeguchi F; Nakayama M; Nakao T
    Ther Apher Dial; 2008 Jun; 12(3):243-9. PubMed ID: 18503703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of icodextrin dialysis solution on body weight and fat accumulation over time in CAPD patients.
    Cho KH; Do JY; Park JW; Yoon KW
    Nephrol Dial Transplant; 2010 Feb; 25(2):593-9. PubMed ID: 19767632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycation and advanced glycation end-product formation with icodextrin and dextrose.
    Dawnay AB; Millar DJ
    Perit Dial Int; 1997; 17(1):52-8. PubMed ID: 9068023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of icodextrin-based dialysis solution on peritoneal leptin clearance.
    Opatrná S; Opatrný K; Racek J; Sefrna F
    Perit Dial Int; 2003; 23(1):89-91. PubMed ID: 12691516
    [No Abstract]   [Full Text] [Related]  

  • 12. Understanding the variability in ultrafiltration obtained with icodextrin.
    Lambie M; Stompor T; Davies S
    Perit Dial Int; 2009; 29(4):407-11. PubMed ID: 19602605
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of peritoneal dialysis with icodextrin in the long-term treatment of refractory congestive heart failure.
    Basile C; Chimienti D; Bruno A; Cocola S; Libutti P; Teutonico A; Cazzato F
    Perit Dial Int; 2009; 29(1):116-8. PubMed ID: 19164263
    [No Abstract]   [Full Text] [Related]  

  • 14. Icodextrin dialysate improves nutritional and inflammatory profiles in peritoneal dialysis patients.
    Lin W; Chen YC; Wu MS; Hsu HJ; Sun CY; Lin YK; Wu IW
    Ren Fail; 2009; 31(2):98-105. PubMed ID: 19212905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant intra- and interpatient variation in ultrafiltration achieved by icodextrin in APD patients.
    Liakopoulos V; Zarogiannis S; Eleftheriadis T; Dovas S; Stefanidis I
    Perit Dial Int; 2007; 27(1):97-8. PubMed ID: 17179521
    [No Abstract]   [Full Text] [Related]  

  • 16. Strategy for preventing peritoneal dialysis failure.
    Cancarini G
    Contrib Nephrol; 2001; (131):114-24. PubMed ID: 11125557
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence-based medicine in peritoneal dialysis: peritoneal dialysis solutions.
    Feriani M
    Contrib Nephrol; 2003; (140):202-8. PubMed ID: 12800361
    [No Abstract]   [Full Text] [Related]  

  • 18. Icodextrin: a review of its use in peritoneal dialysis.
    Frampton JE; Plosker GL
    Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of icodextrin-based solutions on peritoneal transport in rats undergoing chronic peritoneal dialysis.
    Pawlaczyk K; Garcia-Lopez E; Kuzlan-Pawlaczyk M; Heimbürger O; Bergström J; Breborowicz A; Lindholm B
    Perit Dial Int; 2001; 21 Suppl 3():S359-61. PubMed ID: 11887855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose monitoring for diabetic patients using icodextrin.
    Wang R; Skoufos L; Martis L
    Perit Dial Int; 2004; 24(3):296-7. PubMed ID: 15185782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.